Search Results - "Yessayan, Lenar T"

Association of Systolic Blood Pressure Variability With Mortality, Coronary Heart Disease, Stroke, and Renal Disease by Gosmanova, Elvira O., MD, Mikkelsen, Margit K., BS, Molnar, Miklos Z., MD, PhD, Lu, Jun L., MD, Yessayan, Lenar T., MD, MS, Kalantar-Zadeh, Kamyar, MD, MPH, PhD, Kovesdy, Csaba P., MD

“…Abstract Background Intraindividual blood pressure (BP) fluctuates dynamically over time. Previous studies suggested an adverse link between greater…”
Get full text

Translation of immunomodulatory therapy to treat chronic heart failure: Preclinical studies to first in human by Humes, H David, Aaronson, Keith D, Buffington, Deborah A, Sabbah, Hani N, Westover, Angela J, Yessayan, Lenar T, Szamosfalvi, Balazs, Pagani, Francis D

“…Inflammation has been associated with progression and complications of chronic heart failure (HF) but no effective therapy has yet been identified to treat…”
Get full text

Long-term decline in renal function is more significant after endovascular repair of infrarenal abdominal aortic aneurysms by Al Adas, Ziad, Shepard, Alexander D., Nypaver, Timothy J., Weaver, Mitchell R., Maatman, Thomas, Yessayan, Lenar T., Balraj, Praveen, Kabbani, Loay S.

“…It is not clear whether endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs) results in an increase in renal insufficiency during the long…”
Get full text

Extracorporeal Immunomodulation Treatment and Clinical Outcomes in ICU COVID-19 Patients by Yessayan, Lenar T, Neyra, Javier A, Westover, Angela J, Szamosfalvi, Balazs, Humes, H David

“…To evaluate safety and clinical outcomes of extracorporeal immunomodulation treatment with a selective cytopheretic device (SCD) in COVID-19 ICU patients with…”
Get full text

Safety Summary of the Selective Cytopheretic Device: A Review of Safety Data Across Multiple Clinical Trials in ICU Patients With Acute Kidney Injury and Multiple Organ Failure by Humes, H. David, Goldstein, Stuart L., Yessayan, Lenar T., Catanzaro, David A., Scribe, Emily C., Iyer, Sai Prasad N., Chung, Kevin K.

“…OBJECTIVES: Acute kidney injury (AKI) requiring continuous kidney replacement therapy is a significant complication in ICU patients with mortality rates…”
Get full text

Increasing Eligibility to Transplant Through the Selective Cytopheretic Device: A Review of Case Reports Across Multiple Clinical Conditions by Iyer, Sai Prasad N, Pino, Christopher J, Yessayan, Lenar T, Goldstein, Stuart L, Weir, Matthew R, Westover, Angela J, Catanzaro, David A, Chung, Kevin K, Humes, H David

“…A stable, minimum physiological health status is required for patients to qualify for transplant or artificial organ support eligibility to ensure the…”
Get full text

Citrate Anticoagulation for Continuous Kidney Replacement Therapy: An Embarrassment of RICH-es by Szamosfalvi, Balazs, Yessayan, Lenar T., Heung, Michael

Get full text

Towards Consensus in Timing of Kidney Replacement Therapy for Acute Kidney Injury? by Sohaney, Ryann, Yessayan, Lenar T., Heung, Michael

Get full text

Management of dysnatremias with continuous renal replacement therapy by Yessayan, Lenar T., Szamosfalvi, Balazs, Rosner, Mitchell H.

“…Disorders of serum sodium concentration are common in critically ill patients who may have concomitant acute kidney injury, chronic kidney disease, or…”
Get full text

Extracorporeal Immunomodulation Therapy in Acute Chronic Liver Failure With Multiorgan Failure: First in Human Use by Yessayan, Lenar T, Sharma, Pratima, Westover, Angela J, Szamosfalvi, Balazs, Humes, H David

“…Two patients presented with acute on chronic liver failure and multiorgan failure and, as typical for this disorder, they presented with hyperinflammation and…”
Get full text

Use of extracorporeal immunomodulation in a toddler with hemophagocytic lymphohistiocytosis and multisystem organ failure by Goldstein, Stuart L., Yessayan, Lenar T., Krallman, Kelli A., Collins, Michaela, Benoit, Stefanie, Westover, Angela, Humes, H. David

“…Introduction Hemophagocytic lymphohistiocytosis (HLH) is a dysregulated immune disorder in children, associated with Epstein–Barr virus (EBV) infection or…”
Get full text

HIV infection presenting proliferation of CD8+ T lymphocyte and hemophagocytic lymphohistiocytosis by Usman, Mohammad, Thapa, Sudeep D, Hadid, Hiba, Yessayan, Lenar T

“…Hemophagocytic lymphohistiocytosis is a rare hyperinflammatory disorder characterised by CD8+ T lymphocyte activation and hypercytokinemia. Autoimmune…”
Get more information

Change in Lactate Levels After Hemodialysis in Patients With End-Stage Renal Disease by Hourmozdi, Justin J., Gill, Jasreen, Miller, Joseph B., Markin, Abraham, Adams, Beth, Soi, Vivek, Jaehne, Anja K., Taylor, Andrew R., Langberg, Sam, Rodriguez, Lauren, Fox, Carynne, Uduman, Junior, Yessayan, Lenar T., Rivers, Emanuel P.

“…Patients with end-stage renal disease commonly visit the emergency department (ED). The purpose of this investigation is to examine the prevalence of baseline…”
Get full text

Online Hemoglobin and Oxygen Saturation Sensing During Continuous Renal Replacement Therapy with Regional Citrate Anticoagulation by Yessayan, Lenar T, Yee, Jerry, Frinak, Stan, Szamosfalvi, Balazs

“…Optical hemoglobin and oxygen saturation sensor (OHOS) monitor when used in combination with other hemodynamic tools may be useful for continuous hemodynamic…”
Get full text

Lipoteichoic Acid as a Potential Noninvasive Biomarker of Biofilm in Dialysis Access by Pai, Amy Barton, McGuire, Matthew D., Davidge, Karen N., Dean, Michael C., Costello, Gabrielle M., Souza, Ernane, Mukherjee, Sushovita, Heung, Michael, Yevzlin, Alexander S., Yessayan, Lenar T.

“…Tunneled central venous catheters (TCVCs) are colonized by Gram-positive organisms and form biofilm. Lipoteichoic acid (LTA) is a Gram-positive cell wall…”
Get full text

Role of Immunomodulation Therapy with Selective Cytopheretic Device (SCD) in Reversing Acute on Chronic Liver Failure (ACLF) with Hepatorenal Syndrome (HRS) and Multi-Organ Failure: FR-PO135 by Yessayan, Lenar T., Sharma, Pratima, Westover, Angela, Szamosfalvi, Balazs, Humes, H. David

Get full text

Safety Summary of the Selective Cytopheretic Device (SCD): A Review of Safety Data Across Multiple Clinical Trials in ICU Patients with AKI and Multi-Organ Failure: FR-PO136 by Catanzaro, David, Goldstein, Stuart, Yessayan, Lenar T., Chung, Kevin K., Scribe, Emily, Humes, H. David

Get full text

SCD Treatment in COVID-19 ICU Patients with ARDS and AKI Is Safe and May Improve Clinical Outcomes: PO2523 by Yessayan, Lenar T., Neyra, Javier A., Westover, Angela, Szamosfalvi, Balazs, Humes, H. David

Get full text

Multi-Center Study to Assess the Safety of a Selective Cytopheretic Device (SCD) for Treatment of Immunomodulatory Dysregulation due to AKI in Children ≥10 and ≤20 kg: Report From the First 4 Patients: TH-PO039 by Krallman, Kelli A., French, Xavier, David Humes, H., Askenazi, David J., Yessayan, Lenar T., Collins, Michaela, Potts, Jessica, Goldstein, Stuart

Get full text

CRRT Circuit Patency in Patients with COVID-19 and AKI: PO0694 by Shaikhouni, Salma, Sohaney, Ryann, Ludwig, John T., Tilea, Anca, Bitzer, Markus, Yessayan, Lenar T., Heung, Michael

Get full text